Your browser does not support JavaScript!
Skip to main content
IRBManager
CTSU
Search form
Search
Toggle navigation
Home
About
Our Mission
Our History
Who's Involved
About the Boards
CIRB SOPs
List of Institutions
Studies
For New Users
Overview of the Study Review Process
Frequently Asked Questions about Navigating IRBManager
When To Use NCI CIRB, IRBManager, and CTSU Websites
For Institutions
IRBManager Basics
Overview of the Study Review Process
Become A Signatory Institution
Navigate the CIRB For NCI Division of Cancer Prevention Consortia Sites And Cancer Prevention Clinical Trial Network (CP-CTNET) Organizations
Create and Update the Signatory Institution Worksheet
Create and Update the Annual Principal Investigator Worksheet
Open a Study
Change the PI on a Study
Submit a Study Closure
Report A Potential Unanticipated Problem Or A Serious Or Continuing Noncompliance
Request an Assent Waiver
Notify the CIRB About the Participation of an Incarcerated Participant
For Networks
Overview of the Study Review Process
CIRB Document Posting
Submitting Studies
CIRB Meeting Schedules
For Board Members
Become A Board Member
Overview of the Study Review Process
Resources
CIRB Meeting Schedules
Contact Us
Home
Change in CIRB Review Process of Adverse Event Reports for Phase 3 Clinical Trials
CIRB Home >>
Policies
04.01.2010
Change in CIRB Review Process of Adverse Event Reports for Phase 3 Clinical Trials
CIRB_AE_Review_Process_Memo_040110.pdf
Close
Your browser does not support JavaScript!
